Astrazeneca Pharma India informs about press release

11 Mar 2024 Evaluate
Astrazeneca Pharma India has enclosed copy of press release in connection with a Distribution and Promotion Agreement entered into by the Company with Mankind Pharma for the distribution of budesonide and formoterol fumarate dihydrate (brand name Symbicort) in India. Further, details as required under the SEBI Circular SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 attached as Annexure - A, in this regard.

The above information is a part of company’s filings submitted to BSE. 

Astrazeneca Pharma I Share Price

8225.05 -62.30 (-0.75%)
20-Jan-2026 12:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.80
Dr. Reddys Lab 1185.50
Cipla 1379.40
Zydus Lifesciences 876.55
Lupin 2165.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×